Insiders · Profile

Riley Jennifer

Chief Strategy Officer at Avalo Therapeutics. Filing since 11 Aug 2026. CIK 0002047607

Company

Date

Role

Action

Amount

Of holding

11 Aug 2026

Chief Strategy Officer

Sold at will

2,655

$52.01K

6.7%

1 decision on file.